• -
17 Results
A reflection of Planet Earth appears on a water drop on a leaf.
Reflections on Tragedy
Days after the attacks on the World Trade Center, William Martin, the Harry and Hazel Chavanne Senior Fellow in Religion and Public Policy and Chavanne Emeritus Professor in Rice’s Department of Sociology, spoke to a gathering of Rice University students, faculty and staff. These are his remarks. 
William Martin September 12, 2018
Map syringe
Needle Exchanges Prevent Disease Without Promoting Drugs
The Texas House of Representatives is considering House Bill 3256, which would legalize syringe exchange programs (SEPs) as a means of reducing the transmission of infectious and communicable diseases among people who inject drugs. On April 25, William Martin, director of the Drug Policy Program, appeared before the Texas House Committee on Public Health to testify in support of HB 3256. Martin also authored an op-ed in TribTalk supporting the establishment of SEPs.
William Martin May 10, 2017
Israel flag
Keeping the Faith in Israel for a Two-state Solution
Despite right-wing pushes for the annexation of a significant portion of the West Bank, support remains for a two-state solution to the ongoing Israeli-Palestinian conflict. Yair Hirschfeld, fellow in the Center for the Middle East, analyzes Israel's political environment in this post on the Baker Institute Blog.
Yair Hirschfeld November 24, 2015
RX Medicine
Viewpoints: The Future of Treatment in Drug Policy
Drug policy has experienced an interesting shift recently. Along with legalization of medical and recreational marijuana, many states are also reducing penalties for nonviolent drug offenses and placing greater focus on treatment for drug users. The emphasis on treatment and rehabilitation for drug users is the result of many factors, including recognition that the drug war has not reduced drug use, a desire to reduce the prison population and save money, and a surge in the rate of overdoses from opioid and heroin use. What remains to be seen is whether the current popularity of drug treatment will become a more permanent feature of drug policy. In this Baker Institute Viewpoints series, five experts on drug policy examine the question, “Is the current emphasis on treatment in drug policy a short-term trend or is it here to stay?”
Katharine Neill Harris, William Martin December 19, 2014